Buscar
Mostrando ítems 1-10 de 112
Safety and tolerability of inhaled budesonide in children in the Steroid Treatment As Regular Therapy in early asthma (START) trial
(2006)
The safety and tolerability of asthma medications are still a concern to many asthma patients receiving long-term treatment. Therefore, more safety data from long-term, controlled trials are needed. The aim of this study ...
Inflammatory and functional effects of increasing asthma treatment with formoterol or double dose budesonide
(W B SAUNDERS CO LTD, 2008)
Adding a long-acting beta(2)-agonist to inhaled corticosteroids (ICS) for asthma treatment is better than increasing ICS dose in improving clinical status, although there is no consensus about the impact of this regimen ...
Safety of long-term intranasal budesonide delivered via the mucosal atomization device for chronic rhinosinusitis
(John Wiley & Sons, 2017)
BACKGROUND: Although short-term use (≤2 months) of atomized topical nasal steroids has been
shown to be safe and effective, the long-term safety has yet to be demonstrated. The aim of this
study was to determine the ...
Safety of long-term intranasal budesonide delivered via the mucosal atomization device for chronic rhinosinusitis
(John Wiley & Sons, 2017)
BACKGROUND: Although short-term use (≤2 months) of atomized topical nasal steroids has been
shown to be safe and effective, the long-term safety has yet to be demonstrated. The aim of this
study was to determine the ...
Outcome of pregnancy in a randomized controlled study of patients with asthma exposed to budesonide
(American College of Allergy, Asthma and Immunology, 2005)
Background: Budesonide is the only inhaled corticosteroid to be given a category B pregnancy rating by the US Food and Drug Administration, based on observational data from the Swedish Medical Birth Registry. However, data ...
Budesonide-hydroxypropyl-beta-cyclodextrin inclusion complex in binary poloxamer 407/403 system for ulcerative colitis treatment: A physico-chemical study from micelles to hydrogels
(Elsevier B.V., 2016-02-01)
Budesonide (BUD) is a glucocorticoid widely used for the treatment of ulcerative colitis. In this work, we propose the study of the system BUD-HP-beta-CD inclusion complex incorporated into PL 407 and PL407-PL403 ...